Fortis Healthcare shares reached a 52-week high of Rs 978 on the BSE. At 2:40 pm, the stock was trading at Rs 973.65 on the BSE, a 0.38% increase from the previous close. The stock is a constituent of the Nifty Midcap 150 index.
Financial Performance:
Fortis Healthcare's consolidated financial performance shows consistent growth in revenue and net profit.
Income Statement (Consolidated):
The following table summarizes the company's consolidated income statement:
| Period | Sales (Rs Crore) | Other Income (Rs Crore) | Total Income (Rs Crore) | Total Expenditure (Rs Crore) | EBIT (Rs Crore) | Interest (Rs Crore) | Tax (Rs Crore) | Net Profit (Rs Crore) |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | 7,782 | 66 | 7,849 | 6,669 | 1,179 | 184 | 197 | 797 |
| Mar 2024 | 6,892 | 38 | 6,931 | 5,951 | 979 | 130 | 212 | 635 |
| Mar 2023 | 6,297 | 61 | 6,359 | 5,438 | 920 | 129 | 180 | 611 |
| Mar 2022 | 5,717 | 27 | 5,744 | 4,634 | 1,110 | 146 | 197 | 765 |
| Mar 2021 | 4,030 | 46 | 4,076 | 3,915 | 161 | 165 | 99 | -103 |
The company's sales increased from Rs 6,892 Crore in March 2024 to Rs 7,782 Crore in March 2025. The net profit also increased from Rs 635 Crore in March 2024 to Rs 797 Crore in March 2025.
| Quarter | Sales (Rs Crore) | Other Income (Rs Crore) | Total Income (Rs Crore) | Total Expenditure (Rs Crore) | EBIT (Rs Crore) | Interest (Rs Crore) | Tax (Rs Crore) | Net Profit (Rs Crore) |
|---|---|---|---|---|---|---|---|---|
| Jun 2025 | 2,166 | 15 | 2,182 | 1,764 | 417 | 69 | 83 | 263 |
| Mar 2025 | 2,007 | 19 | 2,027 | 1,727 | 299 | 67 | 48 | 183 |
| Dec 2024 | 1,928 | 20 | 1,949 | 1,626 | 322 | 45 | 25 | 252 |
| Sep 2024 | 1,988 | 13 | 2,001 | 1,708 | 293 | 36 | 67 | 188 |
| Jun 2024 | 1,858 | 13 | 1,871 | 1,607 | 264 | 35 | 56 | 173 |
The company's revenue for the quarter-ending June 2025 was Rs 2,166.72 Crore, compared to Rs 1,858.90 Crore for the quarter-ending June 2024. The net profit for the quarter-ending June 2025 was Rs 263.86 Crore, compared to Rs 173.39 Crore for the quarter-ending June 2024.
Cash Flow:
| Period | Operating Activities (Rs Crore) | Investing Activities (Rs Crore) | Financing Activities (Rs Crore) | Others (Rs Crore) | Net Cash Flow (Rs Crore) |
|---|---|---|---|---|---|
| Mar 2025 | 1,423 | -779 | -713 | 0 | -69 |
| Mar 2024 | 1,100 | -886 | -86 | -2 | 124 |
| Mar 2023 | 822 | -373 | -471 | 1 | -21 |
| Mar 2022 | 865 | -514 | -517 | 13 | -152 |
| Mar 2021 | 485 | -135 | -142 | 4 | 212 |
Balance Sheet:
| Period | Share Capital (Rs Crore) | Reserves & Surplus (Rs Crore) | Current Liabilities (Rs Crore) | Other Liabilities (Rs Crore) | Total Liabilities (Rs Crore) | Fixed Assets (Rs Crore) | Current Assets (Rs Crore) | Other Assets (Rs Crore) | Total Assets (Rs Crore) | Contingent Liabilities (Rs Crore) |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2025 | 754 | 8,161 | 1,607 | 3,167 | 13,691 | 6,636 | 1,471 | 5,584 | 13,691 | 3,136 |
| Mar 2024 | 754 | 6,906 | 3,170 | 2,457 | 13,288 | 6,221 | 1,420 | 5,646 | 13,288 | 2,999 |
| Mar 2023 | 754 | 6,485 | 1,425 | 3,767 | 12,433 | 5,513 | 1,406 | 5,514 | 12,433 | 2,834 |
| Mar 2022 | 754 | 5,423 | 1,269 | 4,437 | 11,884 | 5,485 | 1,133 | 5,265 | 11,884 | 2,607 |
| Mar 2021 | 754 | 5,362 | 1,233 | 3,803 | 11,154 | 5,242 | 1,036 | 4,875 | 11,154 | 1,936 |
Financial Ratios:
| Ratio | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 |
| Diluted Eps (Rs.) | 10.26 | 7.93 | 7.80 | 7.35 | -1.45 |
| Book Value /Share (Rs.) | 118.11 | 113.33 | 107.30 | 92.83 | 88.98 |
| Dividend/Share (Rs.) | 1.00 | 1.00 | 1.00 | 0.00 | 0.00 |
| Face Value | 10 | 10 | 10 | 10 | 10 |
| Gross Profit Margin (%) | 21.26 | 18.94 | 18.46 | 19.17 | 11.19 |
| Operating Margin (%) | 16.30 | 13.97 | 13.45 | 13.91 | 3.98 |
| Net Profit Margin (%) | 10.25 | 9.22 | 9.70 | 13.39 | -2.57 |
| Return on Networth / Equity (%) | 8.68 | 7.81 | 8.12 | 8.98 | -1.79 |
| ROCE (%) | 10.50 | 9.52 | 7.69 | 7.49 | 1.61 |
| Return On Assets (%) | 5.65 | 4.50 | 4.73 | 4.67 | -0.98 |
| Current Ratio (X) | 0.92 | 0.45 | 0.99 | 0.89 | 0.84 |
| Quick Ratio (X) | 0.84 | 0.41 | 0.90 | 0.80 | 0.78 |
| Debt to Equity (x) | 0.25 | 0.11 | 0.10 | 0.16 | 0.19 |
| Interest Coverage Ratios (X) | 8.97 | 9.97 | 9.01 | 7.47 | 0.97 |
| Asset Turnover Ratio (%) | 0.58 | 0.54 | 0.09 | 0.08 | 36.12 |
| Inventory Turnover Ratio (X) | 69.89 | 0.00 | 0.00 | 0.00 | 52.50 |
| 3 Yr CAGR Sales (%) | 16.67 | 30.78 | 16.60 | 13.11 | -6.00 |
| 3 Yr CAGR Net Profit (%) | 2.07 | 147.56 | 177.58 | 14.11 | -67.59 |
| P/E (x) | 68.07 | 52.99 | 33.32 | 39.51 | -137.34 |
| P/B (x) | 5.91 | 4.14 | 2.71 | 3.55 | 2.45 |
| EV/EBITDA (x) | 33.04 | 25.16 | 17.90 | 21.26 | 36.26 |
| P/S (x) | 6.78 | 4.60 | 3.12 | 3.83 | 3.73 |
Corporate Actions:
Fortis Healthcare announced a final dividend of Rs 1.00 per share (10%) on May 20, 2025, with an effective date of July 25, 2025. The company also announced a final dividend of Rs 1.00 per share on May 23, 2024, and May 24, 2023.
Additionally, the company had a rights issue with an announce date of August 10, 2009, offering 2 shares for every 5 existing shares, with a face value of Rs 10 and a premium of Rs 100. Another rights issue was announced on December 24, 2008, with the same terms.
Moneycontrol analysis indicates a very bullish sentiment on the stock as of September 15, 2025.
With the stock currently trading near its 52-week high, Fortis Healthcare exhibits a strong market presence and positive financial trajectory.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
